Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
292
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Santen Pharmaceutical
•
27 Apr 2022 23:09
Santen Pharmaceutical (4536 JP): Future Is Uncertain Beyond Eylea
Santen’s key drug to face biosimilar competition is the major overhang on the company’s near-term growth potential. The company does not have any...
Tina Banerjee
Follow
313 Views
Share
bearish
•
Samsung Biologics
•
12 Apr 2022 14:42
Samsung Biologics: Post-Offering Trading Dynamics on Potential Overhang
This post discusses Samsung Biologics' post-offering trading dynamics on potential overhang as a little more than 1M new shares, 22x ADTV, will...
Sanghyun Park
Follow
432 Views
Share
bullish
•
Celltrion Inc
•
21 Mar 2022 17:32
Celltrion and Celltrion Health Placement - Past Deals Have Been Mixed
Temasek aims to raise around US$450m+ via selling 1.7% of Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) each.
Sumeet Singh
Follow
346 Views
Share
bullish
•
SK Bioscience
•
13 Mar 2022 22:44
SK Bioscience (302440 KS): An Attractive Pure-Play on Vaccines- Both COVID and Non-COVID
SK Bioscience’s near-term growth will be driven by CMO contract of Novavax COVID-19 vaccine. The company’s rich non-COVID pipeline and global...
Tina Banerjee
Follow
232 Views
Share
bullish
•
Samsung SDI
•
26 Feb 2022 06:28
FnGuide Samsung Group Index Rebalancing Preview
FnGuide Samsung Group Index has the largest AUM among the locally-themed indexes. This post previews the upcoming rebalancing in June.
Sanghyun Park
Follow
355 Views
Share
First
Previous
13
14
15
16
17
18
19
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x